Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/29/2007 | CN101024037A Medicine for treating non-insulin-depending type diabetes |
08/29/2007 | CN101024034A Ginseng, astragalus diabetes dropping pills |
08/29/2007 | CN101024032A Medicine made from onion and semen cassiae and preparing method |
08/29/2007 | CN101024009A Compounded zhidi total extract and its preparation and use |
08/29/2007 | CN101023969A Hippophate flavone powder capsule and its preparing method |
08/29/2007 | CN101023968A Coenzyme composition preparing method |
08/29/2007 | CN101023958A Buccal tablet of Asraguluspolysacharin |
08/29/2007 | CN101023948A Rimonabant and cyclodextrin inclusion compound of its salt capable of being as medicine, its preparing method and medicine use |
08/29/2007 | CN101023943A Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases |
08/29/2007 | CN101023803A Chinese wolf-berry pumpkin drink |
08/29/2007 | CN101023790A Chinese-wolfberry-fruit flavouring product |
08/29/2007 | CN101023772A Gastrodia-walnut health-care sweet |
08/29/2007 | CN101023768A Hawthorn blood-pressure-reducing tea |
08/29/2007 | CN101023767A Bamboo charcoal tea-cube |
08/29/2007 | CN101023765A Gastrodia tuber health-care tea |
08/29/2007 | CN101023762A 奶粥 Milk porridge |
08/29/2007 | CN100334109C GLP-1 analogues |
08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
08/29/2007 | CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands |
08/29/2007 | CN100333787C YG and YGG used as maintenance and improvement of immunoreaction |
08/29/2007 | CN100333741C Medicine for preventing and treating diabets and kidney disease and preparing method |
08/29/2007 | CN100333731C Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
08/29/2007 | CN100333728C Compound electrolytic fructose injection |
08/29/2007 | CN100333719C Hyperlipemia-treating Chinese traditional medicinal tablet and its preparation process |
08/29/2007 | CN100333716C Prepn. process of micron hypoglycemic stomach benefiting health medicine granule, capsule and tablet |
08/29/2007 | CN100333713C Method for preparing milk contg. micron sugared-ginseng and bee-glue for tonifying-Yin and lowering blood-sugar |
08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
08/28/2007 | US7262221 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders |
08/28/2007 | US7262218 Polymorphic forms are suitable for use as active substances of pharmaceutical dosage forms for reduction of serum cholesterol levels in the bloodstream |
08/28/2007 | US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
08/28/2007 | US7262201 Quinazoline derivatives |
08/28/2007 | US7262199 Tyrosine kinase inhibitors |
08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
08/28/2007 | US7261896 Methods for preventing strokes by inducing tolerance to e-selectin |
08/28/2007 | US7261893 Neutralizing antibodies against GDF-8 and uses therefor |
08/28/2007 | US7261880 Methods of treating Syndrome X with aliphatic polyamines |
08/28/2007 | CA2405072C Gel compositions containing metronidazole |
08/28/2007 | CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them |
08/28/2007 | CA2293338C Isomer enriched conjugated linoleic acid compositions |
08/28/2007 | CA2278507C Method for treatment of cns-involved lysosomal storage diseases |
08/28/2007 | CA2222103C Inositolglycans having insulin-like action |
08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
08/23/2007 | WO2007095607A1 Use of benzo-heteroaryl sulfamide derivatives for lowering lipids and lowering blood glucose levels |
08/23/2007 | WO2007094497A1 Ameliorating agent for metabolic syndrome |
08/23/2007 | WO2007094360A1 Process for producing polysaccharide from coffee bean or/and coffee extraction residue |
08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
08/23/2007 | WO2007093880A2 Novel pyrone-indole derivatives and process for their preparation |
08/23/2007 | WO2007093853A2 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols |
08/23/2007 | WO2007093806A1 Dissolution aids for oral peptide delivery comprising a biguanide |
08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
08/23/2007 | WO2007093363A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
08/23/2007 | WO2007093264A1 Mandelic hydrazides |
08/23/2007 | WO2007056275A3 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
08/23/2007 | WO2006132879A3 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
08/23/2007 | WO2006097337A3 11β-HYDROXYSTEROID DEHYDROGENASES |
08/23/2007 | WO2000021486A3 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
08/23/2007 | US20070199082 Method of diagnosis of obesity |
08/23/2007 | US20070197829 Process for the synthesis and crystalline form agomelatine |
08/23/2007 | US20070197659 Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
08/23/2007 | US20070197633 Novel forms of pravastatin sodium |
08/23/2007 | US20070197623 increases the effect on Sodium-dependent glucose cotransporters (SGLT); for lowering blood glucose; treatment of type 1 and type 2 diabetes; N-(2-Carbamoylethyl)-4-[1-(2-cyano-ethyl)-5-hydroxy-3-isopropyl-1H-pyrazol-4-ylmethyl]benzamide |
08/23/2007 | US20070197602 Combined pharmaceutical composition |
08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
08/23/2007 | US20070197501 Use Of Chemotherapeutic Agents |
08/23/2007 | US20070197499 Pharmaceutical compounds |
08/23/2007 | US20070197498 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents |
08/23/2007 | US20070197456 Preparation and diabetic use of Gibberellins |
08/23/2007 | US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
08/23/2007 | US20070197449 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
08/23/2007 | US20070196446 Conjugated fatty acid esters |
08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
08/23/2007 | US20070196354 Method of treating diabetes by inhibiting degradation of at least one of crebl1, atf6, and hnf-4 alpha by htra |
08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
08/23/2007 | DE20023910U1 Pharmakologisch wirksame Substanz zur Behandlung kardiovasulärer Erkrankungen Pharmacologically active substance for treating diseases kardiovasulärer |
08/23/2007 | DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists |
08/23/2007 | CA2642847A1 Dissolution aids for oral peptide delivery comprising a biguanide |
08/23/2007 | CA2642473A1 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
08/23/2007 | CA2642232A1 Mandelic hydrazides |
08/23/2007 | CA2641673A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
08/23/2007 | CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
08/23/2007 | CA2636605A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
08/23/2007 | CA2556305A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
08/22/2007 | EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
08/22/2007 | EP1820797A1 Substituted pyridone derivative |
08/22/2007 | EP1819684A1 Substituted piperazines as cb1 antagonists |
08/22/2007 | EP1819681A1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
08/22/2007 | EP1819672A1 Indole-2-carboxylic acid amides |
08/22/2007 | EP1819332A2 Pyrrolopyridine-2-carboxylic acid amides |
08/22/2007 | EP1819319A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
08/22/2007 | EP1819227A1 Pharmaceutical formulation of decitabine |
08/22/2007 | EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
08/22/2007 | EP1687292B1 Vitamin d receptor modulators |